Do Its Financials Have Any Role To Play In Driving Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Stock Up Recently?
Do Its Financials Have Any Role To Play In Driving Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Stock Up Recently?
Merit Medical Systems' (NASDAQ:MMSI) stock is up by a considerable 19% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually dictate market outcomes. In this article, we decided to focus on Merit Medical Systems' ROE.
過去三個月，Merit Medical Systems (納斯達克:MMSI) 的股價上漲了 19%。我們在想，該公司的財務狀況是否在這次價格波動中起了什麼作用，因爲一家公司的長期基本面通常會決定市場的結果。在本文中，我們決定關注Merit Medical Systems的roe。
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
roe或權益回報率是評估公司有效利用股東投資產生回報效率的有用工具。簡而言之，roe顯示每個股東投資所產生的利潤。
How Is ROE Calculated?
淨資產收益率怎麼計算？
Return on equity can be calculated by using the formula:
股東權益報酬率可以使用以下公式計算：
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
淨資產收益率 = 淨利潤（從持續經營中獲得）÷ 股東權益
So, based on the above formula, the ROE for Merit Medical Systems is:
因此，根據上述公式，Merit Medical Systems的roe爲:
8.2% = US$102m ÷ US$1.2b (Based on the trailing twelve months to March 2024).
8.2% = 1.02億美元 / 12億美元（基於截至2024年3月的過去12個月）。
The 'return' is the amount earned after tax over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.08.
“回報”是稅後過去12個月的賺取金額。因此，這意味着對於股東每投資1美元，公司會產生0.08美元的利潤。
Why Is ROE Important For Earnings Growth?
ROE對於盈利增長的重要性是什麼？
Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
因此，我們已經了解到ROE衡量公司如何高效地創造利潤。根據公司重新投資或“保留”的利潤數量以及其有效性，我們隨後能夠評估公司的收益增長潛力。假設其他所有因素均保持不變，則ROE和利潤保留率越高，相對於不一定具備這些特徵的公司，公司的增長率就越高。
A Side By Side comparison of Merit Medical Systems' Earnings Growth And 8.2% ROE
Merit Medical Systems盈利增長和8.2%的roe的並列比較
When you first look at it, Merit Medical Systems' ROE doesn't look that attractive. A quick further study shows that the company's ROE doesn't compare favorably to the industry average of 11% either. In spite of this, Merit Medical Systems was able to grow its net income considerably, at a rate of 44% in the last five years. We reckon that there could be other factors at play here. Such as - high earnings retention or an efficient management in place.
當你第一次看到Merit Medical Systems的roe時，它看起來並不那麼有吸引力。進一步的快速調查顯示，該公司的roe與行業平均水平（11%）也不相比。儘管如此，Merit Medical Systems在過去五年中能夠以44%的速度大幅增加其淨利潤。我們認爲，這裏可能有其他因素在起作用，比如高利潤保留或者高效的管理。
We then compared Merit Medical Systems' net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 8.7% in the same 5-year period.
然後，我們將Merit Medical Systems的淨收入增長與行業進行了比較，我們很高興地看到，相較於同一5年期間增長率爲8.7%的行業，該公司的增長數字更高。
Earnings growth is an important metric to consider when valuing a stock. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Merit Medical Systems''s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.
盈利增長是考慮股票價值時重要的指標。投資者了解市場是否已經定價該公司的預期盈利增長（或下降）非常重要。通過這樣做，他們將會知道股票是前進到清澈的藍水區，還是會遇到污泥沼澤。如果你想了解Merit Medical Systems的估值，可以查看與行業相比的市盈率評估。
Is Merit Medical Systems Efficiently Re-investing Its Profits?
Merit Medical Systems是否有效地再投資其利潤？
Given that Merit Medical Systems doesn't pay any regular dividends to its shareholders, we infer that the company has been reinvesting all of its profits to grow its business.
鑑於Merit Medical Systems不向股東支付任何常規股息，我們推斷出該公司一直在重新投資其所有利潤以促進業務增長。
Summary
總的來說，我們對偉明環保的表現非常滿意。具體而言，我們喜歡公司以高回報率再投資了其利潤的很大一部分。當然，這導致公司的收益大幅增長。但是，最新的行業分析師預測表明，該公司的收益預計將加速增長。
In total, it does look like Merit Medical Systems has some positive aspects to its business. With a high rate of reinvestment, albeit at a low ROE, the company has managed to see a considerable growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.
總體而言，Merit Medical Systems的業務有一些積極的因素。儘管roe較低，但是該公司進行了高比例再投資，並且成功地實現了收益的顯著增長。儘管如此，最新的行業分析師預測表明，該公司的盈利增長預計將放緩。要了解更多有關該公司最新分析師預測的信息，請查看此視覺化分析師預測。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋？關於內容有所顧慮？直接和我們聯繫。或者，發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論，只使用公正的方法論，我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議，也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意，我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有反饋？關於內容有所顧慮？直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。
譯文內容由第三人軟體翻譯。